Two-year ocular and developmental outcomes of a phase 1 dosing study of bevacizumab for retinopathy of prematurity

Authors :: David K. Wallace
Amra Hercinovic
Sharon F. Freedman
Eric R. Crouch
Amit R. Bhatt
M. Elizabeth Hartnett
Michael B. Yang
David L. Rogers
Amy K. Hutchinson
William V. Good
Michael X. Repka
Raymond T. Kraker
Susan A. Cotter
Jonathan M. Holmes
Source :: Journal of American Association for Pediatric Ophthalmology and Strabismus. 26:e11
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

ISSN :: 10918531
Volume :: 26
Database :: OpenAIRE
Journal :: Journal of American Association for Pediatric Ophthalmology and Strabismus
Accession number :: edsair.doi...........f7005b65f0c5365f26a2e063828fb2bc

Tools